Ribavirin aerosol for acute bronchiolitis
Clicks: 391
ID: 112215
1986
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
5.1
/100
17 views
17 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A randomised double blind placebo controlled trial of treatment with an aerosolised antiviral agent, ribavirin, was conducted in 26 infants with clinically diagnosed bronchiolitis. Nebulised ribavirin (14 infants) or normal saline aerosol (12 infants) was given for 18 hours a day for at least three …
| Reference Key |
w1986archivesribavirin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Barry W;Cockburn F;Cornall R;Price JF;Sutherland G;Vardag A;; |
| Journal | archives of disease in childhood |
| Year | 1986 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Infant
newborn
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Random Allocation
acute disease
bronchiolitis
aerosols
viral / drug therapy*
ribavirin / administration & dosage
ribavirin / therapeutic use*
respiratory syncytial viruses
pmid:3524473
pmc1777824
doi:10.1136/adc.61.6.593
w barry
f cockburn
a vardag
respirovirus infections / drug therapy*
ribonucleosides / therapeutic use*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.